This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Biolase Inc (BIOL)

NASDAQ: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 11.70M 31.56M 1.44M 2.54M
Receivables 8.95M 9.00M 11.13M 11.68M
Inventories 12.57M 12.51M 11.38M 11.14M
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 34.80M 54.80M 25.85M 26.92M
Property, Plant & Equipment, Gross 10.04M 6.96M 8.80M 8.03M
Accumulated Depreciation & Depletion 6.31M 5.67M 6.97M 6.52M
Property, Plant & Equipment, Net 3.73M 1.29M 1.83M 1.51M
Intangibles 51.00K 114.00K 183.00K 300.00K
Other Non-Current Assets 747.00K 270.00K 249.00K 305.00K
Total Non-Current Assets 7.45M 4.61M 5.18M 5.06M
Liabilities & Shareholder Equity
Total Assets 42.25M 59.40M 31.04M 31.97M
Accounts Payable 5.96M 8.36M 8.56M 7.66M
Short Term Debt 0.00 0.00 4.63M 1.64M
Other Current Liabilities 445.00K 139.00K 0.00 4.57M
Total Current Liabilities 15.11M 16.15M 21.94M 19.38M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 738.00K 677.00K 617.00K 663.00K
Other Non-Current Liabilities 1.32M 519.00K 1.00K 141.00K
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 2.22M 1.20M 618.00K 804.00K
Total Liabilities 17.33M 17.35M 22.56M 20.18M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 24.93M 42.06M 8.48M 11.79M
Common Par 58.00K 58.00K 38.00K 34.00K
Additional Paid In Capital 188.62M 185.23M 148.87M 140.75M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -162.95M -142.68M -123.75M -112.27M
Treasury Stock 0.00 0.00 -16.40M -16.40M
Other Equity Adjustments -801.00K -557.00K -274.00K -320.00K
Total Capitalization 24.93M 42.06M 8.48M 11.79M
Total Equity 24.93M 42.06M 8.48M 11.79M
Total Liabilities & Stock Equity 42.25M 59.40M 31.04M 31.97M
Total Common Shares Outstanding 58.23M 58.12M 35.37M 32.07M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 1.97M 2.06M
Basic Weighted Shares Outstanding 58.19M 42.23M 32.58M 32.10M
Diluted Weighted Shares Outstanding 58.19M 42.23M 32.58M 32.10M
Number of Employees 200 210 220 219
Number of Part-Time Employees 0 0 0 0
BIOL News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for BIOL

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET BIOL ANALYST REPORT

BIOL Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs